Novo Holdings Verona Pharma PLC Transaction History

Novo Holdings

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$5.72 - $9.09 $441,326 - $701,338	-77,155 Reduced 9.2%	761,205 $4.98 Million
Q1 2021 May 17, 2021	SELL	$7.08 - $9.33 $12.5 Million - $16.5 Million	-1,770,395 Reduced 67.86%	838,360 $7.01 Million
Q4 2020 Feb 16, 2021	BUY	$5.51 - $8.11 $4.45 Million - $6.55 Million	808,008 Added 44.87%	2,608,755 $18.3 Million
Q3 2020 Nov 16, 2020	BUY	$4.45 - $10.2 $4.72 Million - $10.8 Million	1,060,007 Added 143.1%	1,800,747 $11.2 Million
Q3 2017 Nov 14, 2017	BUY	$11.96 - $16.95 $8.86 Million - $12.6 Million	740,740	740,740 $11.4 Million

218

70.5M

1.4M

299K

Ticker VRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,954,200
Market Cap $3.8B
Description
Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...

Get notified when there are updates to the investment portfolio of Novo Holdings, based on Form 13F filings with the SEC.

Stay updated on Novo Holdings with notifications on news.